Co-Head of Research, Adamas Healthcare Fund
Dr. Ofir Levi is an accomplished biotech entrepreneur with 15 years of experience establishing, managing and investing in early to late stage life science companies. He is the co-head of research at Adamas Healthcare Fund since its inception in 2014 where he leads a research team that conducts deep scientific analysis of publicly traded pharmaceutical and biotechnology companies.
Prior to launching Adamas Healthcare Fund, Ofir was the founder and CEO at Bioassociate Ltd., an expertise-based consulting, research and analysis company focused on the pharmaceutical, biotechnology and life science sectors.
Until 2011, Ofir was the CEO of Radmor Biocap LLC, a company that invested and managed seed and early stage companies pharmaceutical development, clinical diagnostics and medical devices. Led by Dr. Levi Radmor, signed several license agreements with leading universities around the world for novel technologies, and established companies developing these technologies.
Ofir completed his PhD studies in Prof. Daniel Michaelson’s neurobiology lab at Tel-Aviv University. During the 4 years of his PhD studies, he led a research group in both in-house research and several international collaborations. Dr. Levi’s PhD thesis focused on neurogenesis processes in Alzheimer's Disease.